Michael Friedman, MD
- 9Articles
- 33.9KReads1
- 2005–2017Active
- 23Collaborators
- 170Citations2
About
Michael Friedman, MD, has contributed extensively to research on depression, particularly major depressive disorder (MDD), and its assessment through self-report scales. His work focuses on the measurement of depression severity, remission criteria, and the clinical implications of differing patient and clinician perspectives on remission status. Additionally, he has explored topics related to treatment selection, side effects recognition, and the impact of weight in the context of depression treatment. His publications often address the development and validation of brief clinical scales and the evaluation of antidepressant prescribing patterns.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
